Brazil · Series B startup

Who invested in Mevo

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcarePharma

Raised 7 months ago

Funding summaryUpdated 5 Nov 2026

$18Mraised across 1 round since 2026, from 1 source

Latest round
Series B, $18MMar 2026
Led by
Prosus Ventures
Investors
4 (1 led)
See who backed them

The rounds

  1. Mar 2026

Everyone who backed them

Prosus VenturesVC firm1round, led 1
MatrixHedge fund1round
Floating PointVC firm1round
Jefferson River CapitalFamily office1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Mevo as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Matrix PartnersVC firmPer its own site
Dedicated VCVC firmPer its own site
4equity - Media VenturesVC firmPer its own site
Stax VenturesVC firmPer its own site
Vox CapitalVC firmPer its own site

Quick answers about Mevo

Who invested in Mevo?

Mevo's investors include Prosus Ventures, Matrix, Floating Point and Jefferson River Capital. Prosus Ventures led its latest round.

How much has Mevo raised?

Mevo has raised $18M across 1 round since 2026.

When did Mevo last raise?

Mevo's most recent round was a Series B of $18M in Mar 2026, led by Prosus Ventures.

What was Mevo's biggest round?

Its most recent round, $18M in Mar 2026, is also its largest on record.

Who backed Mevo first?

Mevo's first round on record, in Mar 2026, was backed by Prosus Ventures, Matrix and Floating Point and 1 others.

What stage is Mevo at?

Mevo's latest named round is a Series B, in Mar 2026.

Where is Mevo based?

Mevo is based in Brazil.

Who led Mevo's rounds?

Prosus Ventures led the Series B in 2026.

Companies like Mevo

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.